
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5850557
[patent_doc_number] => 20060233748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease'
[patent_app_type] => utility
[patent_app_number] => 10/932208
[patent_app_country] => US
[patent_app_date] => 2004-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28442
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233748.pdf
[firstpage_image] =>[orig_patent_app_number] => 10932208
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/932208 | Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease | Aug 30, 2004 | Abandoned |
Array
(
[id] => 7026471
[patent_doc_number] => 20050020504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases'
[patent_app_type] => utility
[patent_app_number] => 10/926800
[patent_app_country] => US
[patent_app_date] => 2004-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42512
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926800 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | Aug 24, 2004 | Issued |
Array
(
[id] => 7024869
[patent_doc_number] => 20050019263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Conjugate for differentiating between healthy and unhealthy tissue'
[patent_app_type] => utility
[patent_app_number] => 10/917907
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2135
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019263.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917907 | Conjugate for differentiating between healthy and unhealthy tissue | Aug 12, 2004 | Abandoned |
Array
(
[id] => 7074287
[patent_doc_number] => 20050147555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same'
[patent_app_type] => utility
[patent_app_number] => 10/916155
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 79
[patent_no_of_words] => 83348
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10916155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/916155 | Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same | Aug 10, 2004 | Issued |
Array
(
[id] => 7011377
[patent_doc_number] => 20050065093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Inhibitors of the ICE/ced-3 family of cysteine proteases'
[patent_app_type] => utility
[patent_app_number] => 10/914981
[patent_app_country] => US
[patent_app_date] => 2004-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17038
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065093.pdf
[firstpage_image] =>[orig_patent_app_number] => 10914981
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/914981 | Inhibitors of the ICE/ced-3 family of cysteine proteases | Aug 9, 2004 | Abandoned |
Array
(
[id] => 1077093
[patent_doc_number] => 07615609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'Preparation of somatostatin peptides'
[patent_app_type] => utility
[patent_app_number] => 10/567299
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5801
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615609.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567299
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567299 | Preparation of somatostatin peptides | Aug 5, 2004 | Issued |
Array
(
[id] => 7427675
[patent_doc_number] => 20040265899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Solid phase synthesis supports and methods'
[patent_app_type] => new
[patent_app_number] => 10/900240
[patent_app_country] => US
[patent_app_date] => 2004-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8904
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10900240
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/900240 | Solid phase synthesis supports and methods | Jul 26, 2004 | Issued |
Array
(
[id] => 5834227
[patent_doc_number] => 20060246057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Treatment or prevention of damage due to radiation exposure'
[patent_app_type] => utility
[patent_app_number] => 10/564766
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3578
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564766 | Treatment or prevention of damage due to radiation exposure | Jul 18, 2004 | Abandoned |
Array
(
[id] => 202668
[patent_doc_number] => 07632803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Metal-binding compounds and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/894860
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 62
[patent_no_of_words] => 31674
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632803.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894860
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894860 | Metal-binding compounds and uses therefor | Jul 18, 2004 | Issued |
Array
(
[id] => 672367
[patent_doc_number] => 07091314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-15
[patent_title] => 'Intermediates and methods for making heptapeptide oxytocin analogues'
[patent_app_type] => utility
[patent_app_number] => 10/888704
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6687
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/091/07091314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10888704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/888704 | Intermediates and methods for making heptapeptide oxytocin analogues | Jul 7, 2004 | Issued |
Array
(
[id] => 7264929
[patent_doc_number] => 20040242465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Nucleotide analogs'
[patent_app_type] => new
[patent_app_number] => 10/882022
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 68479
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10882022
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/882022 | Nucleotide analogs | Jun 28, 2004 | Issued |
Array
(
[id] => 5769632
[patent_doc_number] => 20060020120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Methods for removing suspended particles from soluble protein solutions'
[patent_app_type] => utility
[patent_app_number] => 10/873801
[patent_app_country] => US
[patent_app_date] => 2004-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5859
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20060020120.pdf
[firstpage_image] =>[orig_patent_app_number] => 10873801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/873801 | Methods for removing suspended particles from soluble protein solutions | Jun 20, 2004 | Abandoned |
Array
(
[id] => 5172375
[patent_doc_number] => 20070072808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Antimicrobial and anticancer lipopeptides'
[patent_app_type] => utility
[patent_app_number] => 10/560727
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13228
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560727 | Antimicrobial and anticancer lipopeptides | Jun 17, 2004 | Issued |
Array
(
[id] => 7319574
[patent_doc_number] => 20040225109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides'
[patent_app_type] => new
[patent_app_number] => 10/869076
[patent_app_country] => US
[patent_app_date] => 2004-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16055
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225109.pdf
[firstpage_image] =>[orig_patent_app_number] => 10869076
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/869076 | Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides | Jun 16, 2004 | Issued |
Array
(
[id] => 7351822
[patent_doc_number] => 20040248894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Insecticidal peptidomimetics of trypsin modulating oostatic factor'
[patent_app_type] => new
[patent_app_number] => 10/868486
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6392
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248894.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868486 | Insecticidal peptidomimetics of trypsin modulating oostatic factor | Jun 14, 2004 | Abandoned |
Array
(
[id] => 7317599
[patent_doc_number] => 20040224366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Valency platform molecules comprising aminooxy groups'
[patent_app_type] => new
[patent_app_number] => 10/867874
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 25725
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10867874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/867874 | Valency platform molecules comprising aminooxy groups | Jun 13, 2004 | Abandoned |
Array
(
[id] => 7027288
[patent_doc_number] => 20050020814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method for renaturating proteins'
[patent_app_type] => utility
[patent_app_number] => 10/865135
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5078
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865135
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865135 | Method for renaturating proteins | Jun 9, 2004 | Abandoned |
Array
(
[id] => 7252175
[patent_doc_number] => 20040259164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Capture and release based isotope tagged peptides and methods for using the same'
[patent_app_type] => new
[patent_app_number] => 10/863589
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15314
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259164.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863589
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863589 | Capture and release based isotope tagged peptides and methods for using the same | Jun 6, 2004 | Issued |
Array
(
[id] => 7264942
[patent_doc_number] => 20040242478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => '5-cnac as oral delivery agent for parathyroid hormone fragments'
[patent_app_type] => new
[patent_app_number] => 10/484331
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3196
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484331
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484331 | 5-cnac as oral delivery agent for parathyroid hormone fragments | Jun 2, 2004 | Abandoned |
Array
(
[id] => 7297247
[patent_doc_number] => 20040214784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids'
[patent_app_type] => new
[patent_app_number] => 10/851096
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 9625
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214784.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851096
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851096 | Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids | May 23, 2004 | Issued |